173 related articles for article (PubMed ID: 12722096)
1. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma.
Okuyama T; Oya M; Ishikawa H
J Surg Oncol; 2003 May; 83(1):42-7. PubMed ID: 12722096
[TBL] [Abstract][Full Text] [Related]
2. Budding (sprouting) as a useful prognostic marker in colorectal mucinous carcinoma.
Okuyama T; Oya M; Yamaguchi M
Jpn J Clin Oncol; 2002 Oct; 32(10):412-6. PubMed ID: 12451038
[TBL] [Abstract][Full Text] [Related]
3. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma.
Park KJ; Choi HJ; Roh MS; Kwon HC; Kim C
Dis Colon Rectum; 2005 Aug; 48(8):1597-602. PubMed ID: 15937624
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.
Ueno M; Oya M; Azekura K; Yamaguchi T; Muto T
Br J Surg; 2005 Jun; 92(6):756-63. PubMed ID: 15838895
[TBL] [Abstract][Full Text] [Related]
5. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.
Wang HS; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Chang SC; Lin JK
Dis Colon Rectum; 2005 Jun; 48(6):1182-92. PubMed ID: 15793641
[TBL] [Abstract][Full Text] [Related]
6. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma.
Ohtsuki K; Koyama F; Tamura T; Enomoto Y; Fujii H; Mukogawa T; Nakagawa T; Uchimoto K; Nakamura S; Nonomura A; Nakajima Y
Anticancer Res; 2008; 28(3B):1831-6. PubMed ID: 18630467
[TBL] [Abstract][Full Text] [Related]
8. Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma.
Okuyama T; Nakamura T; Yamaguchi M
Dis Colon Rectum; 2003 Oct; 46(10):1400-6. PubMed ID: 14530682
[TBL] [Abstract][Full Text] [Related]
9. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
Okuyama T; Oya M; Ishikawa H
Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
[TBL] [Abstract][Full Text] [Related]
10. Indication and benefit of pelvic sidewall dissection for rectal cancer.
Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognostic value of conventional peritoneal lavage cytology in patients undergoing curative colorectal cancer resection.
Noura S; Ohue M; Seki Y; Yano M; Ishikawa O; Kameyama M
Dis Colon Rectum; 2009 Jul; 52(7):1312-20. PubMed ID: 19571710
[TBL] [Abstract][Full Text] [Related]
12. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
[TBL] [Abstract][Full Text] [Related]
13. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
14. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
15. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
16. Budding as a useful determinant of the optimal treatment for T1 rectal carcinomas.
Masaki T; Matsuoka H; Sugiyama M; Abe N; Mori T; Atomi Y; Watanabe T; Nagawa H; Muto T
Hepatogastroenterology; 2003; 50(50):388-91. PubMed ID: 12749229
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer.
Peng J; Xu Y; Guan Z; Zhu J; Wang M; Cai G; Sheng W; Cai S
Ann Surg Oncol; 2008 Nov; 15(11):3118-23. PubMed ID: 18769971
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
[TBL] [Abstract][Full Text] [Related]
19. Depth of mesorectal invasion has prognostic significance in T3N0 low rectal cancer.
Tokoro T; Okuno K; Hida J; Ishimaru E; Ueda K; Yoshifuji T
Hepatogastroenterology; 2009; 56(89):124-7. PubMed ID: 19453042
[TBL] [Abstract][Full Text] [Related]
20. [Clinic study of lateral lymph node metastasis in advanced lower rectal cancer].
Wu ZY; Wan J; Yao Y; Zhao G; Du JL; Yang J
Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):190-2. PubMed ID: 18683713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]